Arteriovenous Fistula Maturation Evaluation Study. FAME Study
Study of the Hemodynamic and Clinical Maturation of the Native Arteriovenous Fistula for Hemodialysis
1 other identifier
observational
86
1 country
1
Brief Summary
Study of the features of hemodynamic and clinical maturation of the native arteriovenous fistula for hemodialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 27, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2022
CompletedMarch 23, 2022
March 1, 2022
3.1 years
January 27, 2021
March 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (60)
Volume flow
Volume of flow in brachial artery in L/min
day 1 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 2 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 3 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 4 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 5 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 6 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 7 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 14 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 21 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 28 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 60 post access creation
Volume flow
Volume of flow in brachial artery in L/min
day 90 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 1 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 2 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 3 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 4 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 5 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 6 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 7 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 14 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 21 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 28 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 60 post access creation
brachial artery diameter
Diameter of the Brachial artery in mm
day 90 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 1 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 2 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 3 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 4 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 5 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 6 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 7 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 14 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 21 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 28 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 60 post access creation
Resistive index RI
Calculation of the Resistive Index of the Brachial artery
day 90 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 1 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 2 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 3 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 4 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 5 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 6 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 7 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 14 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 21 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 28 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 60 post access creation
Diameter of the efferent vein
Diameter of the the efferent vein in mm
day 90 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 1 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 2 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 3 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 4 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 5 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 6 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 7 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 14 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 21 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 28 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 60 post access creation
Wall thickness of the efferent vein
Wall thickness of the efferent vein in mm
day 90 post access creation
Secondary Outcomes (4)
Time of first successful cannulation
30 and 60 days
Successful hemodialysis
30 and 60 days
Primary patency
6 months
Surgeon-Nephrologist access site selection concordance
At access creation (day 0)
Study Arms (1)
Dialysis
Patients with hemodialysis-dependent end-stage renal disease and a newly created native arteriovenous fistula
Interventions
Transcutaneous Doppler ultrasound (DUS) study was performed at the mid brachial artery to assess diameter, VF and RI, and at the mid segment of the efferent vein to assess the diameter and wall thickness.
Eligibility Criteria
The study will recruit patients with end-stage renal disease eligible for native arteriovenous fistula creation for hemodialysis fulfilling the study's inclusion critera.
You may qualify if:
- Hemodialysis patients
- new native arteriovenous fistula (AVF)
You may not qualify if:
- Patients not eligible for AVF creation
- Patients with non compensated heart failure New York Heart Association stages 3 and 4
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medifil AElead
- National and Kapodistrian University of Athenscollaborator
- Democritus University of Thracecollaborator
Study Sites (1)
Mediterranean Hospital
Glyfada, Attica, 16675, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ioannis E Giannikouris, MD, MSc, PhD
Mediterranean Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Nephrologist
Study Record Dates
First Submitted
January 27, 2021
First Posted
February 3, 2021
Study Start
February 1, 2019
Primary Completion
February 20, 2022
Study Completion
February 20, 2022
Last Updated
March 23, 2022
Record last verified: 2022-03